Tuesday, June 14, 2016
- 6:00pm-7:00pm
-
Initial Experience with Ledipasvir-Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation.
Poster Session D: Viral Hepatitis • Halls C&D
- 6:00pm-7:00pm
-
Initial Experience with the Bacterial Enzyme IdeS® (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Patients.
Poster Session D: Late Breaking • Halls C&D
- 6:00pm-7:00pm
-
Innate Immune Signaling During Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation.
- 6:00pm-7:00pm
-
Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
- 6:00pm-7:00pm
-
Is CMV Prophylaxis Effective in CMV-Seropositive Patients Receiving Thymoglobulin as Induction Therapy?
- 6:00pm-7:00pm
-
Is SVR Associated with Improved Hepatic Function in Hepatitis C Gen 1 Pts with Cirrhosis 1 Year After Completing Treatment with Sofosbuvir + Simeprevir +/- Ribavirin?
Poster Session D: Viral Hepatitis • Halls C&D
- 6:00pm-7:00pm
-
Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.
- 6:00pm-7:00pm
-
Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function.
Poster Session D: Late Breaking • Halls C&D
- «Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 51
- Next Page»